Status:

COMPLETED

Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity

Lead Sponsor:

Brigham and Women's Hospital

Conditions:

Metabolic Syndrome

Hypertension

Eligibility:

All Genders

18-70 years

Phase:

PHASE4

Brief Summary

This study will evaluate whether the mineralocorticoid receptor antagonist eplerenone, when compared to chlorthalidone plus potassium chloride, can improve cardiac MRI-derived myocardial perfusion res...

Detailed Description

Obesity is a dominant risk factor for the development of cardiovascular disease (CVD). The public health relevance of this relationship is underscored by the fact that 40% (93 million) of adult Americ...

Eligibility Criteria

Inclusion

  • BMI ≥ 30 with at least one of the following, or BMI ≥ 25 with at least two of the following:
  • Untreated Hypertension: Stage I (BP 120-139/80-89 mmHg) or stage II (BP 140-159/90-99 mmHg).
  • Treated Hypertension: On one anti-hypertensive medication with BP\<140/90 mmHg and willing to undergo a 2-week washout of the medication before initiating eplerenone or chlorthalidone + KCl
  • Dysglycemia: Impaired fasting plasma glucose (100-125 mg/dL) or glycated A1c 5.7-6.4%
  • Dyslipidemia: Fasting triglyceride level \> 150 mg/dL and HDL\< 40 mg/dL in men or \<50 mg/dL in women.
  • Age between 18 and 70 years old

Exclusion

  • Estimated glomerular filtration rate \< 60 mL/min/1.73m2)
  • Serum potassium \> 5.2 mEq/L
  • Known diagnosis or treatment for type 1 or type 2 diabetes
  • Known history of CVD (myocardial infarction, heart failure, atrial fibrillation, or stroke)
  • EKG with ischemic ST-segment or T-wave changes or Q waves in more than one territorial lead or a left bundle branch block
  • Pregnancy (verified with a pregnancy test) or breast-feeding

Key Trial Info

Start Date :

December 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 17 2025

Estimated Enrollment :

79 Patients enrolled

Trial Details

Trial ID

NCT04519164

Start Date

December 1 2020

End Date

September 17 2025

Last Update

September 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115